Overview of Dr. Sulis
Dr. Maria Luisa Sulis is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. She received her medical degree from Other and has been in practice 24 years. Dr. Sulis accepts several types of health insurance, listed below. She is one of 135 doctors at New York-Presbyterian Hospital and one of 95 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. She also speaks multiple languages, including Italian and Spanish. She has more than 50 publications and over 500 citings.
Office
1275 York Ave
New York, NY 10065Fax+1 929-321-7097
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1999 - 2002
- Westchester Medical CenterResidency, Pediatrics, 1996 - 1999
- OtherClass of 1993
Certifications & Licensure
- FL State Medical License 2023 - Present
- NY State Medical License 1999 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 1 citationsUniversal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy
Haematologica. 2024-10-01 - Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.Damon R Reed, Asmin Tulpule, Jonathan Metts, Matteo Trucco, Mark Robertson-Tessi
Journal of Clinical Oncology. 2024-09-01 - Vomiting in children and adolescents receiving intravenous pegaspargase: a retrospective study.Jamie M Brown, Sherry Mathew, Maria Luisa Sulis, L Lee Dupuis, Jennifer Thackray
Pediatric Hematology and Oncology. 2024-08-01
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Italian, Spanish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMOEmpire BCBS PPO
Great West PPO
Healthfirst New York
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: